Drugs /

bms-986416

Back to Drugs List

Overview

Clinical Trials

View Clinical Trials for bms-986416

Bms-986416 has been investigated in 1 clinical trial, of which 1 is open and 0 are closed. Of the trial investigating bms-986416, 1 is phase 1 (1 open).

Microsatellite Stable (MSS) is the most frequent biomarker inclusion criterion for bms-986416 clinical trials.

Colorectal carcinoma, head and neck squamous cell carcinoma, and hepatocellular carcinoma are the most common diseases being investigated in bms-986416 clinical trials [2].

Top Biomarker Inclusion Criteria for Open Clinical Trials Investigating Bms-986416
This graph displays the 20 most frequently occurring biomarkers curated on clinical trials investigating bms-986416 and the cancer types associated with these biomarkers. These numbers are derived from a set of 5,956 clinical trials for which biomarker status defines treatment.

Drug Details

Synonyms [2]:
bms986416, bms 986416

References

1. National Cancer Institute. NCI Thesaurus Version 18.11d. https://ncit.nci.nih.gov/ncitbrowser/. [2018-07-30] [2018-08-02].

2. All assertions and clinical trial landscape data are curated from primary sources. You can read more about the curation process here.